<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27240351</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">832</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms17060832</ELocationID><Abstract><AbstractText>Dengue fever is a serious threat for public health and induces various inflammatory cytokines and mediators, including galectins and glycoproteins. Diverse immune responses and immunological pathways are induced in different phases of dengue fever progression. However, the status of serum galectins and glycoproteins is not fully determined. The aim of this study was to investigate the serum concentration and potential interaction of soluble galectin-1, galectin-3, galectin-9, galectin-3 binding protein (galectin-3BP), glycoprotein 130 (gp130), and E-, L-, and P-selectin in patients with dengue fever in acute febrile phase. In this study, 317 febrile patients (187 dengue patients, 150 non-dengue patients that included 48 patients with bacterial infection and 102 patients with other febrile illness) who presented to the emergency department and 20 healthy controls were enrolled. Our results showed the levels of galectin-9 and galectin-3BP were significantly higher in dengue patients than those in healthy controls. Lower serum levels of galectin-1, galectin-3, and E-, L-, and P-selectin in dengue patients were detected compared to bacteria-infected patients, but not to healthy controls. In addition, strong correlation between galectin-9 and galectin-3BP was observed in dengue patients. In summary, our study suggested galectin-9 and galectin-3BP might be critical inflammatory mediators in acute dengue virus infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kuan-Ting</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. kuantingliu7@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. kuantingliu7@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. kuantingliu7@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yao-Hua</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. lau0619@yahoo.com.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. infchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. infchen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu 300, Taiwan. infchen@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. infectionman@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. infectionman@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chung-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. locusthao@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. locusthao@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Meng-Chi</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. 1030605@ms.kmuh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Po-Lin</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. kuopolin@seed.net.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science and Technology, National Sun Yat-Sen University, Kaohsiung 804, Taiwan. kuopolin@seed.net.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000951">Antigens, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037161">Galectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C081856">LGALS3BP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105032">LGALS9 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000951" MajorTopicYN="N">Antigens, Neoplasm</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037161" MajorTopicYN="N">Galectins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adult</Keyword><Keyword MajorTopicYN="N">dengue</Keyword><Keyword MajorTopicYN="N">fever</Keyword><Keyword MajorTopicYN="N">galectin</Keyword><Keyword MajorTopicYN="N">galectin-3 binding protein</Keyword><Keyword MajorTopicYN="N">galectin-9</Keyword><Keyword MajorTopicYN="N">glycoprotein</Keyword><Keyword MajorTopicYN="N">serum</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27240351</ArticleId><ArticleId IdType="pmc">PMC4926366</ArticleId><ArticleId IdType="doi">10.3390/ijms17060832</ArticleId><ArticleId IdType="pii">ijms17060832</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., Hunsperger E., Kroeger A., Margolis H.S., Martinez E., et al. Dengue: A continuing global threat. Nat. Rev. Microbiol. 2010;8:S7&#x2013;S16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Global Strategy for Dengue Prevention and Control. World Health Organization Press; Geneva, Switzerland: 2012.</Citation></Reference><Reference><Citation>Guzman M.G., Harris E. Dengue. Lancet. 2015;385:453&#x2013;465. doi: 10.1016/S0140-6736(14)60572-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60572-9</ArticleId><ArticleId IdType="pubmed">25230594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.F., Wang W.H., Chang K., Chen Y.H., Tseng S.P., Yen C.H., Wu D.C., Chen Y.M. Severe dengue fever outbreak in Taiwan. Am. J. Trop. Med. Hyg. 2016;94:193&#x2013;197. doi: 10.4269/ajtmh.15-0422.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.15-0422</ArticleId><ArticleId IdType="pmc">PMC4710429</ArticleId><ArticleId IdType="pubmed">26572871</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiwan national infectious disease statistics system   [(accessed on 3 February 2016)];Taipei (Taiwan): Taiwan Centers for Disease Control. 2016  Available online:  http://nidss.cdc.gov.tw/en/</Citation></Reference><Reference><Citation>Wang S.F., Chang K., Lu R.W., Wang W.H., Chen Y.H., Chen M., Wu D.C., Chen Y.M. Large dengue virus type 1 outbreak in Taiwan. Emerg. Microbes Infect. 2015;4:e46. doi: 10.1038/emi.2015.46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2015.46</ArticleId><ArticleId IdType="pmc">PMC4576165</ArticleId><ArticleId IdType="pubmed">26421269</ArticleId></ArticleIdList></Reference><Reference><Citation>Limon-Flores A.Y., Perez-Tapia M., Estrada-Garcia I., Vaughan G., Escobar-Gutierrez A., Calderon-Amador J., Herrera-Rodriguez S.E., Brizuela-Garcia A., Heras-Chavarria M., Flores-Langarica A., et al. Dengue virus inoculation to human skin explants: An effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int. J. Exp. Pathol. 2005;86:323&#x2013;334. doi: 10.1111/j.0959-9673.2005.00445.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0959-9673.2005.00445.x</ArticleId><ArticleId IdType="pmc">PMC2517443</ArticleId><ArticleId IdType="pubmed">16191104</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessie K., Fong M.Y., Devi S., Lam S.K., Wong K.T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 2004;189:1411&#x2013;1418. doi: 10.1086/383043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/383043</ArticleId><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>Suharti C., van Gorp E.C.M., Setiati T.E., Dolmans W.M.V., Djokomoeljanto R.J., Hack C.E., ten Cate H., van der Meer J.W.M. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb. Haemostasis. 2002;87:42&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">11858187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., Bozza P.T., Kubelka C.F. Multiplex cytokine profile from dengue patients: MIP-1&#x3b2; and IFN-&#x3b3; as predictive factors for severity. BMC Infect. Dis. 2008;8:832. doi: 10.1186/1471-2334-8-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-8-86</ArticleId><ArticleId IdType="pmc">PMC2474613</ArticleId><ArticleId IdType="pubmed">18578883</ArticleId></ArticleIdList></Reference><Reference><Citation>Juffrie M., van der Meer G.M., Hack C.E., Haasnoot K., Sutaryo, Veerman A.J.P., Thijs L.G. Inflammatory mediators in dengue virus infection in children: Interleukin-8 and its relationship to neutrophil degranulation. Infect. Immun. 2000;68:702&#x2013;707. doi: 10.1128/IAI.68.2.702-707.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.68.2.702-707.2000</ArticleId><ArticleId IdType="pmc">PMC97195</ArticleId><ArticleId IdType="pubmed">10639436</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.C., Lei H.Y., Liu C.C., Shiesh S.C., Chen S.H., Liu H.S., Lin Y.S., Wang S.T., Shyu H.W., Yeh T.M. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hyg. 2006;74:142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro-Sanchez E., Despres P., Cedillo-Barron L. Innate immune responses to dengue virus. Arch. Med. Res. 2005;36:425&#x2013;435. doi: 10.1016/j.arcmed.2005.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2005.04.007</ArticleId><ArticleId IdType="pubmed">16099317</ArticleId></ArticleIdList></Reference><Reference><Citation>Green A.M., Beatty P.R., Hadjilaou A., Harris E. Innate immunity to dengue virus infection and subversion of antiviral responses. J. Mol. Biol. 2014;426:1148&#x2013;1160. doi: 10.1016/j.jmb.2013.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.11.023</ArticleId><ArticleId IdType="pmc">PMC4174300</ArticleId><ArticleId IdType="pubmed">24316047</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta G.R., Ahmed H., Nita-Lazar M., Banerjee A., Pasek M., Shridhar S., Guha P., Fernandez-Robledo J.A. Galectins as self/non-self recognition receptors in innate and adaptive immunity: An unresolved paradox. Front. Immunol. 2012;3:199. doi: 10.3389/fimmu.2012.00199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00199</ArticleId><ArticleId IdType="pmc">PMC3396283</ArticleId><ArticleId IdType="pubmed">22811679</ArticleId></ArticleIdList></Reference><Reference><Citation>Chagan-Yasutan H., Ndhlovu L.C., Lacuesta T.L., Kubo T., Leano P.S.A., Niki T., Oguma S., Morita K., Chew G.M., Barbour J.D., et al. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. J. Clin. Virol. 2013;58:635&#x2013;640. doi: 10.1016/j.jcv.2013.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.10.022</ArticleId><ArticleId IdType="pmc">PMC3880569</ArticleId><ArticleId IdType="pubmed">24239423</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo K.A., Fermino M.L., Andrade C.D., Riul T.B., Alves R.T., Muller V.D.M., Russo R.R., Stowell S.R., Cummings R.D., Aquino V.H., et al. Galectin-1 exerts inhibitory effects during DENV-1 infection. PLoS ONE. 2014;9:832. doi: 10.1371/journal.pone.0112474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112474</ArticleId><ArticleId IdType="pmc">PMC4231055</ArticleId><ArticleId IdType="pubmed">25392933</ArticleId></ArticleIdList></Reference><Reference><Citation>Murgue B., Cassar O., Deparis X. Plasma concentrations of sVCAM-1 and severity of dengue infections. J. Med. Virol. 2001;65:97&#x2013;104. doi: 10.1002/jmv.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2007</ArticleId><ArticleId IdType="pubmed">11505450</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris D.H., Jenjaroen K., Blacksell S.D., Phetsouvanh R., Wuthiekanun V., Newton P.N., Day N.P., Turner G.D. Differential patterns of endothelial and leucocyte activation in &#x201c;typhus-like&#x201d; illnesses in laos and thailand. Clin. Exp. Immunol. 2008;153:63&#x2013;67. doi: 10.1111/j.1365-2249.2008.03673.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2008.03673.x</ArticleId><ArticleId IdType="pmc">PMC2432098</ArticleId><ArticleId IdType="pubmed">18505434</ArticleId></ArticleIdList></Reference><Reference><Citation>Page A.V., Liles W.C. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 2013;4:507&#x2013;516. doi: 10.4161/viru.24530.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.24530</ArticleId><ArticleId IdType="pmc">PMC5359744</ArticleId><ArticleId IdType="pubmed">23669075</ArticleId></ArticleIdList></Reference><Reference><Citation>Trung D.T., Thao le T.T., Dung N.M., Ngoc T.V., Hien T.T., Chau N.V., Wolbers M., Tam D.T., Farrar J., Simmons C., et al. Clinical features of dengue in a large vietnamese cohort: Intrinsically lower platelet counts and greater risk for bleeding in adults than children. PLoS Negl. Trop. Dis. 2012;6:832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383761</ArticleId><ArticleId IdType="pubmed">22745839</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons C.P., Farrar J.J., Nguyen v V., Wills B. Dengue. N. Engl. J. Med. 2012;366:1423&#x2013;1432. doi: 10.1056/NEJMra1110265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1110265</ArticleId><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreola B., Bressan S., Callegaro S., Liverani A., Plebani M., da Dalt L. Procalcitonin and c-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr. Infect. Dis. J. 2007;26:672&#x2013;677. doi: 10.1097/INF.0b013e31806215e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e31806215e3</ArticleId><ArticleId IdType="pubmed">17848876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatherill M., Tibby S.M., Sykes K., Turner C., Murdoch I.A. Diagnostic markers of infection: Comparison of procalcitonin with C reactive protein and leucocyte count. Arch. Dis. Child. 1999;81:417&#x2013;421. doi: 10.1136/adc.81.5.417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.81.5.417</ArticleId><ArticleId IdType="pmc">PMC1718133</ArticleId><ArticleId IdType="pubmed">10519716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalayanarooj S., Vaughn D.W., Nimmannitya S., Green S., Suntayakorn S., Kunentrasai N., Viramitrachai W., Ratanachu-eke S., Kiatpolpoj S., Innis B.L., et al. Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis. 1997;176:313&#x2013;321. doi: 10.1086/514047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/514047</ArticleId><ArticleId IdType="pubmed">9237695</ArticleId></ArticleIdList></Reference><Reference><Citation>Potts J.A., Rothman A.L. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop. Med. Int. Health. 2008;13:1328&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2756447</ArticleId><ArticleId IdType="pubmed">18803612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuniga E., Gruppi A., Hirabayashi J., Kasai K.I., Rabinovich G.A. Regulated expression and effect of galectin-1 on trypanosoma cruzi-infected macrophages: Modulation of microbicidal activity and survival. Infect. Immun. 2001;69:6804&#x2013;6812. doi: 10.1128/IAI.69.11.6804-6812.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.69.11.6804-6812.2001</ArticleId><ArticleId IdType="pmc">PMC100058</ArticleId><ArticleId IdType="pubmed">11598053</ArticleId></ArticleIdList></Reference><Reference><Citation>Uluca U., Sen V., Ece A., Tan I., Karabel D., Aktar F., Karabel M., Balik H., Gunes A. Serum galectin-3 levels in children with chronic hepatitis B infection and inactive hepatitis B carriers. Med. Sci. Monit. 2015;21:1376&#x2013;1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4548702</ArticleId><ArticleId IdType="pubmed">25968249</ArticleId></ArticleIdList></Reference><Reference><Citation>Park A.M., Hagiwara S., Hsu D.K., Liu F.T., Yoshie O. Galectin-3 plays an important role in innate immunity against gastric infection of Helicobactor pylori. Infect. Immun. 2016;84 doi: 10.1128/IAI.01299-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.01299-15</ArticleId><ArticleId IdType="pmc">PMC4807496</ArticleId><ArticleId IdType="pubmed">26857579</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Komai-Koma M., Gilchrist D.S., Hsu D.K., Liu F.T., Springall T., Xu D. Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J. Immunol. 2008;181:2781&#x2013;2789. doi: 10.4049/jimmunol.181.4.2781.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.4.2781</ArticleId><ArticleId IdType="pubmed">18684969</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S., Niki T., Hirashima M., Horton H. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood. 2012;119:4192&#x2013;4204. doi: 10.1182/blood-2011-11-389585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-389585</ArticleId><ArticleId IdType="pmc">PMC3359739</ArticleId><ArticleId IdType="pubmed">22438246</ArticleId></ArticleIdList></Reference><Reference><Citation>Merani S., Chen W., Elahi S. The bitter side of sweet: The role of galectin-9 in immunopathogenesis of viral infections. Rev. Med. Virol. 2015;25:175&#x2013;186. doi: 10.1002/rmv.1832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1832</ArticleId><ArticleId IdType="pubmed">25760439</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons C.P., Popper S., Dolocek C., Chau T.N., Griffiths M., Dung N.T., Long T.H., Hoang D.M., Chau N.V., Thao le T.T., et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J. Infect. Dis. 2007;195:1097&#x2013;1107. doi: 10.1086/512162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/512162</ArticleId><ArticleId IdType="pmc">PMC4042601</ArticleId><ArticleId IdType="pubmed">17357045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kittl E.M., Hofmann J., Hartmann G., Sebesta C., Beer F., Bauer K., Huber K.R. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection. Clin. Chem. Lab. Med. 2000;38:205&#x2013;208. doi: 10.1515/CCLM.2000.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2000.029</ArticleId><ArticleId IdType="pubmed">10905755</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepojoki J., Strandin T., Hetzel U., Sironen T., Klingstrom J., Sane J., Makela S., Mustonen J., Meri S., Lundkvist A., et al. Acute hantavirus infection induces galectin-3-binding protein. J. Gen. Virol. 2014;95:2356&#x2013;2364. doi: 10.1099/vir.0.066837-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.066837-0</ArticleId><ArticleId IdType="pubmed">25013204</ArticleId></ArticleIdList></Reference><Reference><Citation>Warke R.V., Martin K.J., Giaya K., Shaw S.K., Rothman A.L., Bosch I. Trail is a novel antiviral protein against dengue virus. J. Virol. 2008;82:555&#x2013;564. doi: 10.1128/JVI.01694-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01694-06</ArticleId><ArticleId IdType="pmc">PMC2224358</ArticleId><ArticleId IdType="pubmed">17913827</ArticleId></ArticleIdList></Reference><Reference><Citation>Warke R.V., Becerra A., Zawadzka A., Schmidt D.J., Martin K.J., Giaya K., Dinsmore J.H., Woda M., Hendricks G., Levine T., et al. Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and denv-infected cells. J. Gen. Virol. 2008;89:1605&#x2013;1615. doi: 10.1099/vir.0.2008/000968-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/000968-0</ArticleId><ArticleId IdType="pubmed">18559930</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.W., Chang H.T., Chen C.H., Chen C.H., Lin S.W., Hsu T.L., Wong C.H. Galectin-3 binding protein and galectin-1 interaction in breast cancer cell aggregation and metastasis. J. Am. Chem. Soc. 2015;137:9685&#x2013;9693.</Citation><ArticleIdList><ArticleId IdType="pubmed">26168351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirure V.S., Reynolds N.M., Burdick M.M. Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells. PLoS ONE. 2012;7:832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3435295</ArticleId><ArticleId IdType="pubmed">22970241</ArticleId></ArticleIdList></Reference><Reference><Citation>Warke R.V., Xhaja K., Martin K.J., Fournier M.F., Shaw S.K., Brizuela N., de Bosch N., Lapointe D., Ennis F.A., Rothman A.L., et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J. Virol. 2003;77:11822&#x2013;11832. doi: 10.1128/JVI.77.21.11822-11832.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.21.11822-11832.2003</ArticleId><ArticleId IdType="pmc">PMC229255</ArticleId><ArticleId IdType="pubmed">14557666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou T., Huang D., Zeng R., Ye Z., Zhang Y. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: A systematic review and meta-analysis. Int. J. Clin. Exp. Med. 2015;8:15238&#x2013;15245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658898</ArticleId><ArticleId IdType="pubmed">26629009</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan T., Chang L., Wu L., Yuan Y.F. IL-6 plays a crucial role in HBV infection. J. Clin. Transl. Hepatol. 2015;3:271&#x2013;276. doi: 10.14218/JCTH.2015.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/JCTH.2015.00024</ArticleId><ArticleId IdType="pmc">PMC4721895</ArticleId><ArticleId IdType="pubmed">26807383</ArticleId></ArticleIdList></Reference><Reference><Citation>Migita K., Abiru S., Maeda Y., Daikoku M., Ohata K., Nakamura M., Komori A., Yano K., Yatsuhashi H., Eguchi K., et al. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis c virus infection. Hum. Immunol. 2006;67:27&#x2013;32. doi: 10.1016/j.humimm.2006.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2006.02.025</ArticleId><ArticleId IdType="pubmed">16698422</ArticleId></ArticleIdList></Reference><Reference><Citation>Koraka P., Murgue B., Deparis X., Van Gorp E.C., Setiati T.E., Osterhaus A.D., Groen J. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J. Med. Virol. 2004;72:445&#x2013;450. doi: 10.1002/jmv.20007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20007</ArticleId><ArticleId IdType="pubmed">14748068</ArticleId></ArticleIdList></Reference><Reference><Citation>Khongphatthanayothin A., Phumaphuti P., Thongchaiprasit K., Poovorawan Y. Serum levels of siCAM-1 and sE-selectin in patients with dengue virus infection. Jpn. J. Infect. Dis. 2006;59:186&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">16785701</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>